Hoersholm, 2016-12-06 15:16 CET (GLOBE NEWSWIRE) --
Company announcement No. 25/2016
Chr. Hansen Holding A/S has entered into an agreement with Thomas Schäfer to take up the position of Executive Vice President and Chief Scientific Officer.
Thomas is currently employed as Vice President at Novozymes and will take up his new position as soon as possible, which is expected to be during spring 2017.
A German national, Thomas completed his Ph.D. in Microbiology, Physiology & Biochemistry and worked as an assistant professor at Freie Universität Berlin. He started his commercial career as a post doc and has since 1994 held various senior leadership positions in the R&D space at Novozymes.
Thomas has more than 20 years’ experience in industrial microbiology, R&D, Innovation, business development and M&A, covering both bacteria and enzymes. He has published several papers, and is the co-founder of a number of patents.
Cees de Jong, CEO of Chr. Hansen, says: “I’m pleased to welcome Thomas to Chr. Hansen as we continue to strengthen our capabilities within the microbial platform and our leadership position in bacterial fermentation technology.”
Following this appointment, the Executive Board will consist of: CEO Cees de Jong, CFO Søren Westh Lonning, COO Knud Vindfeldt, and CSO Thomas Schäfer.
For further information, please contact:
Anders Mohr Christensen, Senior Director, Investor Relations
Tel: +45 4574 7618
Camilla Lercke, Head of Media Relations
Tel: +45 5339 2384
About Chr. Hansen
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2015/16 financial year was EUR 949 million. The company has more than 2,700 dedicated employees in 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen A/S. For further information, please visit www.chr-hansen.com.
